Oncology therapy developer Revolution Medicines went public giving an exit to pharmaceutical company Sanofi.

The Globis-backed startup accelerator has chosen 12 participating startups for its sophomore cohort, three months after the demo day for the initial batch.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The Chalmers University of Technology back pain injection spinout floated in an IPO that was oversubscribed by more than four-fold.

Healthcare staff management platform IntelyCare attracted Kaiser Permanente Ventures as a new investor in a series B round that increased its overall funding to $59m.

MRM Technologies has spun off inflammatory bowel disease drug developer MRM Health with $15m from investors including strategic partner DuPont.

MRM Health was set up by Ghent spinout MRM Technologies to develop treatments based on the microbiome and has now concluded its first funding round backed by Qbic and VIB.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The University Technology Fund hopes to tap investment funds and development finance institutions to raise additional capital.

Proceeds from the Novo-backed series B round will be used to advance Spruce Biosciences' congenital adrenal hyperplasia candidate into phase 2 trials.